title: A review on the actual trends of insulin treatment in elderly with diabetes.
abstract: The diabetes of the elderly subjects has two forms: diabetes of long duration, manifesting itself in younger or medium ages, and senile diabetes, appearing above the age of 65 years. The diabetes of the elderly has usually only modest symptoms: it is not ketosic, but in spite of this, in order to avoid the chronic-degenerative complications, it is important to maintain a good, even if not an optimal compensation. The therapeutic intervention cannot neglect a correct alimentary regime and a programmed physical activity in correlation with the clinical conditions of the patient. If the compensation is not achieved only with these tools, one can add oral antidiabetic treatments. In the elderly patients we usually observe primary or secondary failure of the oral antidiabetic treatments, and in such context we have to apply insulin treatment, even in cases of moderate glycometabolic decompensations. While we are waiting for the gene-therapy or the inhalatory insulin preparations, actually there are at disposal only the insulin analogs in rapid, slow and mixed forms. We propose two treatment schemes: (i) The first one consists of three administrations of rapid insulin with the meals, and on dose of slow insulin 2h after the last meal in the evening. (ii) The second scheme consists of one administration of rapid insulin at lunch, one administration of mixed insulin at dinner, with the addition of oral antidiabetics of peripheric action, in the morning and the evening. A better compliance can be obtained, being a fundamental aspect in the elderly diabetics, and a reduction of the number and severity of the hypoglycemia, which are the most important aspects in the elderly diabetes.
authors.affiliation: Department of Aging Sciences, Research Centre The Extreme Senescence, University of Catania, Cannizzaro Hospital, Via Messina 829, I-95124 Catania, Italy. lmotta@unict.it
authors.forename: Massimo
authors.initials: M
authors.lastname: Motta
authors.forename: Ettore
authors.initials: E
authors.lastname: Bennati
authors.forename: Laura
authors.initials: L
authors.lastname: Ferlito
authors.forename: Michela
authors.initials: M
authors.lastname: Passamonte
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Cardillo
authors.forename: Mariano
authors.initials: M
authors.lastname: Malaguarnera
mesh_terms: D000368:Aged; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D007558:Italy / Q000453:epidemiology; D017063:Outcome Assessment, Health Care / Q000639:trends*; D015995:Prevalence
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin